Mercury Biomed augments patent portfolio with newly approved application for management of core body temperature
CLEVELAND, OH – Mercury Biomed announces that the United States Patent and Trademark Office (USPTO) has issued its patent application entitled, “Maintenance of Core Mammalian Body Temperature” (U.S. Patent No. 9,339,412). The patent will provide key intellectual property protection for Mercury’s WarmSmart patient temperature management system.
The claims cover devices and methods for maintaining and adjusting the core temperature of a mammal, and the issuance concludes substantive examination of the patent application by the USPTO. Inventor, Professor Kenneth Diller, Sc.D., Chief Science Officer at Mercury, commented, “We are gratified that the USPTO has recognized the novelty and uniqueness of our method to control core body temperature. We work everyday to continue to build on and strengthen our IP portfolio to further enhance its potential value and therapeutic utility in a wide range of diseases, procedures, and conditions.”
Mercury, additionally, has filed corresponding patent applications, divisional and continuations that will allow the company to pursue additional claims and device embodiments in key markets throughout the world, including Europe.
“The decision of the USPTO and the subsequent issuance of this patent is an important milestone, giving us two patented temperature management products for warming and cooling, and is another valuable addition to our IP portfolio,” stated Brad Pulver, Chief Executive Officer. “The issuance of our second patent strengthens our advantage over knock-off competitors, broadens our strong IP portfolio, and ultimately creates more value and opportunity for Mercury and its shareholders.”